Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anusha Kalbasi

Showing results (41-50 of 76) with videos related to

Pageof 8
Sort By:
Cancer Discovery|August 30, 2018
SD-101 in Combination with Pembrolizumab in Advanced Melanoma: Results of a Phase Ib, Multicenter StudyAntoni Ribas, Theresa Medina, Shivaani Kummar, et al.
Genome Medicine|August 15, 2025
SCAN-ACT: adoptive T cell therapy target discovery through single-cell transcriptomicsStefano Testa, Aastha Pal, Ajay Subramanian, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 4, 2024
Hypofractionated Preoperative Radiation Should Not Yet Be Used as Standard of Care for Extremity and Truncal Soft Tissue SarcomaElizabeth H Baldini, B Ashleigh Guadagnolo, Kilian E Salerno, et al.
Medical Physics|April 28, 2021
Prediction of soft tissue sarcoma response to radiotherapy using longitudinal diffusion MRI and a deep neural network with generative adversarial network-based data augmentationYu Gao, Vahid Ghodrati, Anusha Kalbasi, et al.
Journal for Immunotherapy of Cancer|February 4, 2022
Germline biomarkers predict toxicity to anti-PD1/PDL1 checkpoint therapyJoanne Weidhaas, Nicholas Marco, Aaron W Scheffler, et al.
Journal of Translational Medicine|April 21, 2011
A novel multiplex assay combining autoantibodies plus PSA has potential implications for classification of prostate cancer from non-malignant casesChong Xie, Hyun J Kim, Jonathan G Haw, et al.
Biorxiv : the Preprint Server for Biology|January 27, 2025
IL-9 as a naturally orthogonal cytokine with optimal JAK/STAT signaling for engineered T cell therapyHua Jiang, Sam Limsuwannarot, Kayla R Kulhanek, et al.
Cancers|September 28, 2023
IGF2BP3 as a Prognostic Biomarker in Well-Differentiated/Dedifferentiated LiposarcomaKyle D Klingbeil, Jack Pengfei Tang, Danielle S Graham, et al.
Physics in Medicine and Biology|June 20, 2020
Treatment effect prediction for sarcoma patients treated with preoperative radiotherapy using radiomics features from longitudinal diffusion-weighted MRIsYu Gao, Anusha Kalbasi, William Hsu, et al.
Science Translational Medicine|October 15, 2020
Uncoupling interferon signaling and antigen presentation to overcome immunotherapy resistance due to JAK1 loss in melanomaAnusha Kalbasi, Mito Tariveranmoshabad, Kevin Hakimi, et al.
Pageof 8

Showing results (41-50 of 76) with videos related to

Sort By:
Pageof 8
Cancer Discovery|August 30, 2018
SD-101 in Combination with Pembrolizumab in Advanced Melanoma: Results of a Phase Ib, Multicenter StudyAntoni Ribas, Theresa Medina, Shivaani Kummar, et al.
Genome Medicine|August 15, 2025
SCAN-ACT: adoptive T cell therapy target discovery through single-cell transcriptomicsStefano Testa, Aastha Pal, Ajay Subramanian, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 4, 2024
Hypofractionated Preoperative Radiation Should Not Yet Be Used as Standard of Care for Extremity and Truncal Soft Tissue SarcomaElizabeth H Baldini, B Ashleigh Guadagnolo, Kilian E Salerno, et al.
Medical Physics|April 28, 2021
Prediction of soft tissue sarcoma response to radiotherapy using longitudinal diffusion MRI and a deep neural network with generative adversarial network-based data augmentationYu Gao, Vahid Ghodrati, Anusha Kalbasi, et al.
Journal for Immunotherapy of Cancer|February 4, 2022
Germline biomarkers predict toxicity to anti-PD1/PDL1 checkpoint therapyJoanne Weidhaas, Nicholas Marco, Aaron W Scheffler, et al.
Journal of Translational Medicine|April 21, 2011
A novel multiplex assay combining autoantibodies plus PSA has potential implications for classification of prostate cancer from non-malignant casesChong Xie, Hyun J Kim, Jonathan G Haw, et al.
Biorxiv : the Preprint Server for Biology|January 27, 2025
IL-9 as a naturally orthogonal cytokine with optimal JAK/STAT signaling for engineered T cell therapyHua Jiang, Sam Limsuwannarot, Kayla R Kulhanek, et al.
Cancers|September 28, 2023
IGF2BP3 as a Prognostic Biomarker in Well-Differentiated/Dedifferentiated LiposarcomaKyle D Klingbeil, Jack Pengfei Tang, Danielle S Graham, et al.
Physics in Medicine and Biology|June 20, 2020
Treatment effect prediction for sarcoma patients treated with preoperative radiotherapy using radiomics features from longitudinal diffusion-weighted MRIsYu Gao, Anusha Kalbasi, William Hsu, et al.
Science Translational Medicine|October 15, 2020
Uncoupling interferon signaling and antigen presentation to overcome immunotherapy resistance due to JAK1 loss in melanomaAnusha Kalbasi, Mito Tariveranmoshabad, Kevin Hakimi, et al.
Pageof 8